Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: A multiinstitutional, retrospective review of 50 patients

Author(s): Uno T, Isobe K, Shikama N


Background:Due to the small number of patients and differences in the pathologic classification in most radiotherapy series, information regarding the adequacy of tumor control in patients with ocular-adnexal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is limited.

Methods:A multiinstitutional, retrospective study was performed on 50 patients with Stage IE ocular-adnexal MALT lymphoma who were treated with radiotherapy between 1989 and 1999. The impact of patient characteristics and other variables on tumor control was analyzed.

Results:Responses to radiotherapy include a complete response (CR) in 26 patients, a partial response (PR) in 20 patients, and no change in 4 patients. Forty-nine of 50 patients obtained tumor control in the ocular adnexa at 24 months. Overall, 6 patients exhibited disease recurrence at 4-97 months. Three patients developed recurrence in the ocular adnexa. Two patients had isolated extranodal failure involving the oral floor and the submandibular gland, and one patient experienced failure in the neck lymph node. The initial tumor response had a marginal impact on the development of recurrence. None of the 26 patients who achieved a CR experienced ocular-adnexal recurrence. All three patients who experienced local treatment failure belonged to the initial PR group. In total, five of six patients who developed recurrent disease had obtained a PR after initial radiotherapy. Age, gender, tumor location, and dose of radiotherapy did not influence the development of recurrence. There was only one death due to lymphoma. The 5-year overall survival rate was 91% with a median follow-up of 46 months.

Conclusions:Radiotherapy offers excellent local control with a prolonged clinical course for patients with MALT lymphoma in the ocular adnexa. The initial response to radiotherapy marginally influenced the probability of recurrence.

Similar Articles

WHO classification: tumors of hematopoietic and lymphoid tissues

Author(s): Jaffe ES, Harris NL, Stein H, Vardiman JW

Lymphoreticular tumors of the orbit

Author(s): Fitzpatrick PJ, Macko S

Malignant tumors of the orbit

Author(s): Margo CE, Mulla ZD

Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes

Author(s): Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, et al.

Orbital lymphoma: radiotherapy outcome and complications

Author(s): Stafford SL, Kozelsky TF, Garrity JA

Role of radiotherapy for primary orbital lymphoma

Author(s): Lee SW, Suh CO, Kim GE

Radiation dose to the lens and cataract formation

Author(s): Henk JM, Whitelocke RA, Warrington AP

Primary radiotherapy for localized orbital MALT lymphoma

Author(s): Le QT, Eulau SM, George TI